Vertex Pharmaceuticals (VRTX) Stock News
$VRTX · NASDAQ · HEALTHCARE · 1 stories in 30 daysBORSA has published 1 story on Vertex Pharmaceuticals (VRTX) in the past 30 days. BORSA’s news read on VRTX is balanced at 50/100, based on 1 company event over the past 7 days. Vertex Pharmaceuticals’ next earnings report is scheduled for Monday, Nov 2 after the close.
The wire on $VRTX
newest first · updated · direct subject stories onlyVertex Pharmaceuticals appointed Daniel Brennan to its board of directors, increasing board size from 10 to 11. Brennan, former EVP and CFO of Boston Scientific, received a $400,000 restricted stock unit award vesting in October 2027 and joined the Audit and Finance Committee.
neutral 50 · impact 20The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
Vertex Pharmaceuticals (VRTX) stock: common questions
What is the latest Vertex Pharmaceuticals stock news?
The highest-impact VRTX story BORSA published in the past 30 days:
· Vertex appoints former Boston Scientific CFO Daniel Brennan to board